For a better experience, click the Compatibility Mode icon above to turn off Compatibility Mode, which is only for viewing older websites.

Research Funding Opportunities

Drexel Sponsorship Resources

Drexel's Office of Research & Innovation maintains a list of governmental, industry and foundation sponsorship opportunities for researchers in all topic areas.

View Office of Research & Innovation Sponsor website

College of Medicine-Specific Foundation Funding Opportunities

Foundation & Corporate Relations (FCR) in the Office of Institutional Advancement builds and maintains partnerships with private and corporate foundations and serves as a resource to investigators during the grant proposal development process.

FCR and the College of Medicine will provide investigators with up-to-date funding opportunities available through foundations. The following requests for proposals (RFPs) are listed by submission deadline. Some foundations have recurring deadlines; others may have rolling deadlines.

There are some foundations that limit the number of applications an institution may submit for specific funding opportunities. Therefore, FCR facilitates limited submissions funding opportunities through Drexel’s InfoReady portal and will make known any funding opportunities that require an internal competition.

Investigators interested in pursuing a foundation or corporate grant should contact, executive director, Foundation & Corporate Relations – STEM Unit, pib25@drexel.edu, 215-895-0326.

January 2024

McKnight Foundation – McKnight Scholars Award
McKnight Endowment Fund for Neuroscience

Deadline: January 15, 2024

Amount:  $225,000 paid in equal installments of $75,000 in 2024, 2025, and 2026

Career Stage: Early career and emerging in field

Purpose:
The McKnight Scholar Awards are given to exceptional young scientists who are in the early stages of establishing an independent laboratory and research career. The intent of the program is to foster the commitment by these scientists to research careers that will have an important impact on the study of the brain. The program seeks to support scientists committed to mentoring neuroscientists from underrepresented groups at all levels of training. Applicants for the McKnight Scholar Award must demonstrate their ability to solve significant problems in neuroscience, which may include the translation of basic research to clinical practice. They should demonstrate a commitment to an equitable and inclusive lab environment.

Eligibility
A candidate for a McKnight Scholar Award must work as an independent investigator at a not-for-profit research institution in the United States, must hold a faculty position at the rank of assistant professor, and must have served at that rank for less than four years at the application deadline (exceptions may be made for parental leave). Those holding other titles such as research assistant professor, adjunct assistant professor, professor research track, visiting professor or instructor are not eligible, and time spent in service in those ranks does not count against the four years of service for determining eligibility.

If the host institution does not use professorial titles, a letter from a senior institutional official (e.g., dean or director of research) must confirm that the applicant has their own dedicated institutional resources, laboratory space and/or facilities. A candidate may not hold another award from the McKnight Endowment Fund for Neuroscience that would overlap in time with the Scholar Award. A candidate cannot apply in more than two rounds of competition for a Scholar Award.


Klingenstein Third Generation Foundation
Transformation of Mental Health Care Program

Deadline:
January 15, 2024, 11:59 pm EST
The application portal opens on November 1, 2023

Funding:
The foundation expects to make up to two grant awards. Each award will be in the amount of $100,000 per year over a two-year period, for a total of $200,000 per grant. Payment of the second year of funding is contingent on sufficient progress during the first year of the grant.

Description:
The foundation is soliciting applications for academic investigators conducting research to demonstrate the benefits of novel ways to access or deliver mental health care or prevention approaches that can be implemented at scale. This application is specifically for high-quality research that builds upon promising pilot work and will lead to a larger demonstration project. Requests for service projects and applications that primarily focus on expanding services or measuring quality within an organization will not be reviewed.

Eligibility:
Academic researchers from universities, research institutions, health systems or other settings that are positioned to provide rigorous, high-quality research focused on transforming mental and behavioral health care that improves outcomes for children and adolescents are eligible.

Investigators can be at any stage in their career but must have collected enough pilot data to inform the development of the proposed research project and must be well enough established to lead an effort such as this. For investigators who are early in their career, mentoring is strongly recommended from a more senior academic researcher who has expertise in program development and dissemination. Co-applicants/principal investigators are allowed if they reside at the same institution.


American Federation for Aging Research
Glenn Foundation for Medical Research Postdoctoral Fellowships in Aging Research

Deadline:
January 25, 2024, Letter of Intent
If invited, full application due mid-May 2024

Funding: $75,000 for a one-year fellowship

Career Stage: Postdoctoral fellows (MD, MD/PhD and PhD)

Purpose:
The Glenn Foundation for Medical Research (GFMR), in partnership with the American Federation for Aging Research (AFAR), created the Glenn Foundation for Medical Research Postdoctoral Fellowships in Aging Research to encourage and further the careers of postdoctoral fellows who are conducting research in the basic biology of aging, as well as translating advances in basic research from the laboratory to the clinic. The award is intended to provide significant research and training support to permit these postdoctoral fellows to become established in the field of aging.

The GFMR postdoctoral fellowship program supports research projects concerned with understanding the basic mechanisms of aging as well as projects that have direct relevance to human aging if they show the potential to lead to clinically relevant strategies that address human aging and healthspan. Projects investigating age-related diseases will be considered, but only if approached from the point of view of how basic aging processes may lead to these outcomes. Projects concerning mechanisms underlying common geriatric functional disorders such as frailty will also be considered. Projects that are strictly clinical in nature such as the diagnosis and treatment of disease, health outcomes or the social context of aging are not eligible.

Eligibility:

  • The applicant must be a postdoctoral fellow (MD and/or PhD degree or equivalent) at the start date of the award (July 1, 2024).
  • The proposed research must be conducted at a qualified not-for-profit setting in the United States.
  • Individuals who are employees in the NIH intramural program are not eligible.
  • Postdoctoral fellows in laboratories that receive support as part of a Paul F. Glenn Center for Biology of Aging Research are not eligible to apply.
  • Applicants who will have received more than five years of postdoctoral training at the time of the start of the award must provide a justification for the additional training period.
  • Fellows may not hold any concurrent funding for the same research project.
  • Former GFMR postdoctoral fellowship awardees may apply if the criteria above are met.

February 2024

The Mary Kay Ash Foundation
Innovative/Translational Cancer Research Grant

Limited Submission

Deadline: February 1, 2024

Funding: $100,000 over a two-year period, July 1, 2024 – June 30, 2026

  • The total budget may not exceed $100,000 (combined indirect/direct costs)
  • Equipment and travel costs must be justified
  • Indirect costs must not exceed 15% of direct costs.

Budget format should follow NIH format for a two-year grant ($50,000/year) and include justification.

Purpose:
The Mary Kay Ash Foundation, a funding source for cancer research, is currently accepting applications for innovative grants for translational research of cancers affecting women, including but not limited to breast, cervical, endometrial, ovarian or uterine, or cancers predominantly affecting women. Preliminary data is not required; however it is helpful to include if available. Animal studies are allowed. However, researchers will need to indicate how their studies would impact patient care in the future should their research be successful.

Required application components:

All documents should be PDFs in NIH-format.

  • Research description (6 pages max.)
  • Literature references Cited (2 pages max.)
  • Letters of collaboration/letters of support (3 pages max.)
  • Current financial support (2 pages max.)
  • NIH-format budget and justification
  • NIH-format biosketch or equivalent (5 pages max.)
  • If a co-PI or additional collaborators are included in your research team, please provide a brief resume for each.

Eligibility:

  • One application per institution.
  • Principal investigator must be appointed a full-time assistant professor or higher at the time of application submission and commit a minimum 5% effort.
  • One co-PI is permitted. An NIH-format CV is required in the upload section for the co-PI. Co-PI must meet the same eligibility requirements as PI (full-time assistant professor or higher). Post-doc contributors will need to be listed as co-investigators, not co-PIs. International co-PIs are permitted with the caveat that all funds will be designated to the U.S.-based university.
  • Salary cap equivalent to that of NIH ( $212,100 as of 1/1/23) is imposed.
  • For all documents, please adhere to NIH-format guidelines or similar.

Contact:
For questions, contact Julia.Santosuosso@mkcorp.com.


PhRMA Foundation
Faculty Starter Grant - Translational Medicine

Deadline: February 1, 2024, 12 noon (ET)

Funding: $100,000

Career Stage: Early Career

Purpose:
Given the breadth of the discipline, the PhRMA Foundation's Translational Medicine Program focuses specifically on novel research that uses the "bedside to bench" approach to address unmet needs in the diagnosis, treatment and prevention of disease. The foundation seeks research proposals that focus on identifying unmet clinical needs and developing new diagnostic, experimental, and computational approaches and technologies to improve patient care and management.

Applicants should work with clinical collaborators to identify unmet clinical needs. Proposals should integrate innovative technologies, with advanced biological, chemical, diagnostic and pharmacological sciences and engineering methodologies in areas that include but not are limited to:

  • Genetics (molecular, pharmaco-, population, medical)
  • Genomics (functional, structural, toxico-, pharmaco-, comparative)
  • Systems (biology and pharmacology)
  • Pathways and networks
  • Integrative biology
  • Modeling and simulation
  • Target identification and validation
  • Biomarker identification and validation
  • Molecular epidemiology
  • Imaging
  • Disease modeling

Eligibility

  • Applicants (U.S. and non-U.S. citizens) must be full-time, promotion-eligible, research-intensive faculty employed at a PhD and/or MS degree-granting accredited U.S. university.
  • Applicants must be within the first five years of independent status
  • Applicants must be eligible to apply for independent external research funding by their university.
  • Applicants should not have other substantial sources of research funding. Individuals receiving only intramural funding or start-up funding from their university are eligible to apply. (Applicants are ineligible if they are the principal investigator of an R01 from the National Institutes of Health or a career award from the National Science Foundation.)
  • The Foundation will not consider multiple applications for the same or similar efforts on the same project. If multiple applicants are submitting proposed efforts on the same project, the efforts must be separate activities and not duplicative. This pertains to applications in both categories of our translational medicine programs (postdoctoral fellowships and faculty starter grants).

PhRMA Foundation
Postdoctoral Fellowships - Translational Medicine

Deadline: February 1, 2024, 12 noon (ET)

Amount:  $60,000 per year up to 2 years

Purpose:
Given the breadth of the discipline, the PhRMA Foundation’s Translational Medicine Program focuses specifically on novel research that uses the “bedside to bench” approach to address unmet needs in the diagnosis, treatment and prevention of disease. The foundation seeks research proposals that focus on identifying unmet clinical needs and developing new diagnostic, experimental, and computational approaches and technologies to improve patient care and management. Proposals should integrate innovative technologies, with advanced biological, chemical, diagnostic, and pharmacological sciences and engineering methodologies in areas that include but not are limited to:

  • Genetics (molecular, pharmaco-, population, medical)
  • Genomics (functional, structural, toxico-, pharmaco-, comparative)
  • Systems (biology and pharmacology)
  • Pathways and networks
  • Integrative biology
  • Modeling and simulation
  • Target identification and validation
  • Biomarker identification and validation
  • Molecular epidemiology
  • Imaging
  • Disease modeling

Eligibility

  • Applicants (U.S. and non-U.S. citizens) must currently be in a PhD and/or MS degree-granting accredited U.S. university.
  • Applicants must have a firm commitment from a research supervisor or sponsor at their university.
  • Applicants must hold a PhD, PharmD, MD or appropriate terminal research doctorate. If you do not hold one at the time of application submission, please state in your extended letter when you expect to receive it, as it must be received before funding can begin. Funding can begin as early as July 1, 2024, or as late as December 1, 2024.
  • Applicants must be within their first five years of postdoctoral study at the time of award activation.
  • Applicants who are applying for funds to support postdoctoral work in the laboratory where their graduate work was performed will be given lower preference. One of the objectives of this fellowship is to gain new skills and therefore an ideal candidate will be conducting their research in a new laboratory and not where their graduate work was performed.
  • The Foundation will not consider multiple applications for the same or similar efforts on the same project. If multiple applicants are submitting proposed efforts on the same project, the efforts must be separate activities and not duplicative. This pertains to applications in both categories of our translational medicine program (postdoctoral fellowships and faculty starter grants).

American Federation for Aging Research
Glenn Foundation Discovery Award

Deadline:
February 15, 2024, Letter of Intent
If invited, full application due: late May, 2024

Funding: $175,000 over three years

Purpose:
The Glenn Foundation for Medical Research (GFMR) in collaboration with the American Federation for Aging Research (AFAR), has established the Glenn Foundation Discovery Award. This award was created to support research projects with strong potential to develop pioneering discoveries for understanding the underlying biological mechanisms that govern normal human aging and its related physiological decline. Relevant proposals from any branch of biology are eligible. This funding program specifically seeks to include principal investigators who may not have previously worked in the area of aging, but whose research and expertise are applicable to understanding the biological mechanisms of normal aging and its relevance to age-associated health decline. Projects that characterize aging as a disease, or that focus on specific diseases are discouraged unless the research plan provides direct connections to the biology of aging and/or the prospect of a translational discovery relevant to improving human healthspan.

Eligibility:

  • Must be a full-time faculty member at the rank of assistant professor or higher at the time of the LOI deadline. To be competitive at the assistant professor level, a candidate would be expected to have established R01 or equivalent funding. The Glenn Foundation Discovery Award does not substitute for the R01 funding mechanism, but supports new, rather than incremental, research projects in established laboratories.
  • Must have a strong record of independent publication beyond the postdoctoral level.
  • Cannot be a principal investigator supported through the Paul F. Glenn Centers for Biology of Aging Research.
  • Must conduct the proposed research at qualified not-for-profit setting in the United States.
  • Investigators who may not have previously worked in the area of aging, but whose research interests and expertise are relevant and could lead to discoveries in understanding the biology of normal aging, are strongly encouraged to apply.

March of Dimes Foundation
Pediatric Scientist Development Program

Deadline:
Eligibility deadline: February 15, 2024
Application deadline: April 15, 2024 at 11:59 PM ET

Funding:
$250,000 over two years

Career Stage:
Early career and new faculty researchers

Areas of Research: Pediatrics and its subspecialties

Purpose:
Due to its focus on young scientists who may not have had rigorous experience or training in scientific inquiry or publication, the PSDP program is more flexible in terms of research proposals, and recipient acceptance into the program does not imply a need to conduct and publish novel, breakthrough scientific work in the pediatrics space, as this in and of itself is rare. Rather, the program is a March of Dimes effort to recognize and strengthen the wide breadth of human talent in the pediatrics field and spark a lifelong confidence, passion and commitment to fetal, neonatal and childhood health research that will undoubtedly change not only clinical outcomes, but lives, in the decades to come. As such, research proposals must be translational in nature and relate to the field of pediatrics — with a focus on prematurity, neonatal morbidity and mortality, and fetal and neonatal health equity — but the outcome of the work is less important than the training and shaping of the recipient during the grant period.

Eligibility

  • Candidates must be completing or have completed pediatric residency in the U.S. or Canada.
  • Candidates must be citizens or lawful permanent residents of Canada or the United States.
  • The proposed research project can be categorized as basic, clinical, health services or translational research. The PSDP supports broad research training across research disciplines supported by mentors who are federally and privately funded leaders within their field. In the clinical and translational research disciplines, the PSDP strongly supports candidates who wish to acquire rigorous training in those scientific disciplines listed in the Statement on Clinical and Translational Research Training for the PSDP. For candidates with MD/PhD degrees, the PSDP gives preference to research proposals involving mentors other than those responsible for the candidate's doctoral or postdoctoral training.
  • Candidates must have an MD, DO or MD/PhD degree and must be enrolled in a pediatric training program (applications may be accepted from candidates whose academic training has been interrupted prior to fellowship or who have pursued alternative career tracks and wish to re-enter academic training). Please note that a maximum of 25% of training positions are available for MD/PhD applicants each year. Candidates with PhD degrees alone are not eligible.
  • The proposed mentor has an academic appointment in a department conducive to the proposed research project. The mentor should hold the rank of associate professor or higher.

March 2024

METAvivor
Translational Research Award

Deadline: Letter of intent due: March 11, 2024
Invited applications due: August 22, 2024

Amount:  Up to two years, $300,000 award

Career Stage: Established in field

Purpose:
METAvivor funds research focused on treating established breast cancer metastases to improve outcomes for stage IV metastatic breast cancer patients. We do not fund research that seeks to prevent or diagnose breast cancer metastasis, or that is focused on improving quality of life.

Eligibility:
All individuals with a clinical doctoral degree or with a doctoral degree who are actively engaged in areas of metastatic breast cancer research and treatment are eligible to apply.


METAvivor
Early Career Investigator Award

Deadline: Letter of Intent due March 12, 2024
Invited Applications due: August 21, 2024

Amount: Up to $200,000 over two years

Career Stage: Early Career Investigator Award and Emerging in Field

Purpose: METAvivor funds research focused on treating established breast cancer metastases to improve outcomes for stage IV metastatic breast cancer patients. We do not fund research that seeks to prevent or diagnose breast cancer metastasis, or that is focused on improving quality of life.

Eligibility: Investigators must be within 10 years of their degree award date and within 6 years of starting their first non-tenured position if started


Damon Runyon Cancer Research Foundation
Damon Runyon Fellowship Award

Deadline: March 15, 2024

Funding:

Year of Award

Stipend

Expenses

Year 1

$70,000

$2,000

Year 2

$72,000

$2,000

Year 3

$74,000

$2,000

Year 4

$76,000

$2,000

Purpose:
The Foundation encourages all theoretical and experimental research relevant to the study of cancer and the search for cancer causes, mechanisms, therapies and prevention.

Candidates must apply for the fellowship under the guidance of a sponsor—a scientist (tenured, tenure-track or equivalent position) capable of providing mentorship to the fellow. In addition to aiding in the planning, execution and supervision of the proposed research, the sponsor’s role is to foster the development of the fellow’s overall knowledge, technical and analytical skills, and capacity for scientific inquiry. The sponsor is also expected to assist the fellow in attaining their career goals.

Awards are made to institutions for the support of the fellow under direct supervision of the sponsor. Candidates who have already accepted a postdoctoral research fellowship award are not eligible. (Candidates may hold a T32 at the time of application, but not concurrently with the Damon Runyon Fellowship Award.)

Eligibility:
Applicants must have completed one or more of the following degrees or their equivalent: MD, PhD, MD/PhD, DDS, DVM, DO. The applicant must include a copy of their diploma to confirm date of conferral. (If an applicant has not yet received their PhD diploma but has successfully completed all PhD requirements, including PhD defense, they may submit a letter from the graduate school explicitly stating such, with the date of the successful PhD defense and date of degree conferral.)

Level 1: Basic and physician-scientists must have received their degrees no more than 18 months prior to the application deadline date. Applicants must not have been in their sponsors' labs for more than one year prior to the application deadline date and are expected to devote 100% of their time to Damon Runyon-supported research activities.


Breast Cancer Alliance
Exceptional Project Grants     

Limited Submission: 2 LOIs per institution

Deadline: Letter of Intent due March 31, 2024
If invited, full applications due July 19, 2024, midnight EDT

Amount: $100,000

Career Stage: All career stages

Purpose:
This award recognizes creative, unique and innovative research. The term of the Exceptional Project Grant is one year, beginning on March 1, 2025.

Prior to submission of a formal grant proposal, BCA requires a one-page letter of intent (LOI) and a separate CV. For 2024 grants, those letters will be due on March 31, 2024, and should be emailed to researchgrants@breastcanceralliance.org. The LOI must contain the applicant’s name, job title and institution at the top of the page, and the applicant’s contact information. The document should state the project title and hypothesis, outline the research aim(s) and methods, and include a brief discussion of the project’s potential impact. The CV should be in the current NIH biosketch format.

The grant provides salary support and project costs for a total of $100,000 (distributed over the one-year period as noted above.) Indirect costs, which are included in the $100,000 award, must be limited to 8% of total direct costs.

Eligibility:
Breast Cancer Alliance invites clinical doctors and research scientists at any stage of their careers, including postdocs, whose current proposal is focused on breast cancer, to apply for an Exceptional Project Grant


Breast Cancer Alliance
Young Investigator Grants

Limited Submission: 2 LOIs per institution

Deadline: Letter of Intent due March 31, 2024
If invited, full application due July 19, 2024, EDT

Amount: Two-year grant for a total of $125,000

Career Stage: Early career state, postdocs

Purpose:
This grant is intended to help advance the careers of young researchers who do not yet have their own major grant support but who design and conduct their own independent research projects.

The term of the Young Investigator Grant is two years, beginning on March 1, 2025. The grant provides salary support and project costs for a total of $125,000 (distributed over the two-year period as noted above.) Indirect costs, which are included in the $125,000 award, must be limited to 8% of total direct costs.

Eligibility:
To encourage a commitment to breast cancer research, Breast Cancer Alliance invites clinical doctors and research scientists who are in the early stages of their careers, including postdocs, whose current proposal is focused on breast cancer, to apply for funding for the Young Investigator Grant.

Applicants for the 2025 award must (1) not have held a tenure-track faculty or tenure-track research position for more than four years following completion of their training, as of March 1, 2025; (2) not have been or are not a principal investigator on an NIH R01 or equivalent national/international non-mentored award as of March 1, 2025; and (3) dedicate at least 50% of their work effort to research.

April 2024

Whitehall Foundation

Deadline: April 15, 2024
If invited, full proposal due September 1, 2024

Note: This funder has three deadlines annually.

Amount:

  • Research Grants: Up to $100,000 per year for the two- and three-year research grants.
  • Grants-in-Aid: Up to $30,000 for a one-year period.

Career Stage:
The Foundation emphasizes the support of young scientists at the beginning of their careers and productive senior scientists who wish to move into new fields of interest.

Purpose:
The Foundation is currently interested in basic research in neurobiology, defined as follows: Invertebrate and vertebrate (excluding clinical) neurobiology, specifically investigations of neural mechanisms involved in sensory, motor and other complex functions of the whole organism as these relate to behavior. The overall goal should be to better understand behavioral output or brain mechanisms of behavior.

The Foundation does not support research focused primarily on disease(s) unless it will also provide insights into normal functioning.

The Foundation will accept only one letter of intent per twelve month period per investigator.

Two Types of Grant Programs:

  • Research Grants
    Research grants are available to established scientists of all ages working at accredited institutions in the United States. Applications will be judged on the scientific merit and the innovative aspects of the proposal as well as on the competence of the applicant. Research grants of up to three years will be provided. A renewal grant with a maximum of two years is possible, but it will be awarded on a competitive basis. Research grants will not be awarded to investigators who have already received, or expect to receive, substantial support from other sources, even if it is for an unrelated purpose.
  • Grants-in-Aid
    The Grants-in-Aid program is designed for researchers at the assistant professor level who experience difficulty in competing for research funds because they have not yet become firmly established. Grants-in-Aid can also be made to senior scientists. All applications will be judged on the scientific merit and innovative aspects of the proposal, as well as on past performance and evidence of the applicant’s continued productivity.

Eligibility:
The Foundation emphasizes the support of young scientists at the beginning of their careers and productive senior scientists who wish to move into new fields of interest.

The applicant must meet all of the following eligibility requirements in order to participate in the application process:

  • Appropriate title: must be an assistant professor (or higher). If the institution does not use this title, a letter from the department chair confirming the applicant's eligibility is required.
  • Status: must hold principal investigator status.
  • Independent: must be considered an 'independent investigator' with their own dedicated lab space or with lab space independent of another investigator.
  • The Foundation does not fund investigators who have substantial (approximately $200,000 per year) extramural funding. The Foundation uses the following formula to determine the PIs total extramural funding: Total direct per year plus total indirect per year less any PI salary taken from these grants. If this amount is greater than approximately $200,000 the PI would not be eligible for Whitehall Foundation funding. Startup funds and internal funding are not included in the calculation.

Rolling Deadline

American Federation for Aging Research
Medical Student Training in Aging Research (MSTAR) Program

Deadline:
Interested students should be in touch directly with the National Training Centers to for the program deadline and application materials.

Funding:
The stipend level is approximately $1,980 per month; actual amounts will vary based on the specific appointment period of individual students. Award period: Eight to 12 weeks.

Purpose:
The MSTAR Program provides medical students with an enriching experience in aging-related research and geriatrics, with the mentorship of top experts in the field. This program introduces students to research and academic experiences early in their training that they might not otherwise have during medical school. Positive experiences in the MSTAR program have led many physicians-in-training to pursue academic careers in aging, ranging from basic science to clinical research to health services research. They have joined the growing cadre of physicians and scientists whose specialized knowledge and skills are in great demand as our population ages.

Students participate in an eight- to twelve-week (or two- to three-month, depending on the training site) structured research, clinical and didactic program in geriatrics, appropriate to their level of training and interests. Research projects are offered in basic, translational, clinical or health services research relevant to older people. Most scholars will do their training and research during the summer months. They will also be invited to submit an abstract to present a poster at the annual meeting of the American Geriatrics Society.

Eligibility

  • Any allopathic or osteopathic medical student in good standing, who will have successfully completed one year of medical school at a U.S. institution by June 2024. Evidence of good standing must be provided by the medical school registrar or dean when the student is notified of receiving the award.
  • Applicants must be citizens or non-citizen nationals of the United States, or must have been lawfully admitted for permanent residence (i.e., in possession of a currently valid Alien Registration Receipt Card I-551, or some other legal verification of such status). Individuals on temporary or student visas are not eligible. Due to NIA restrictions, individuals holding PhD, MD, DVM or equivalent doctoral degrees in the health sciences are not eligible to apply to do the MSTAR Program.
  • Additionally, applicants receiving a stipend or salary support from a federal source are not eligible for this program. Applicants may not hold another award or participate in another program concurrently with the MSTAR program, and must participate in the program full-time for a minimum of eight weeks and a maximum of 12 weeks.

Infectious Diseases Society of America
Grants for Emerging Researchers/Clinicians Mentorship Program

Career Stage: Medical Students

Amount: Not specified

Deadline: Ongoing

Description
The G.E.R.M. Program was developed to provide grants to medical students to support a longitudinal, mentored clinical learning and/or research project for up to a year on infectious diseases-related topics, including HIV, under the mentorship of an IDSA or HIVMA member. This program replaced the IDSA Medical Scholars and HIVMA Medical Students Programs.

Eligibility

  • Graduate students
  • Applicants must be medical students (first-, second- or third-year and those in combined degree programs, including MD/MPH and MD/PhD) from an accredited allopathic or osteopathic medical school in the U.S.